Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mengna Ruan"'
Autor:
Cheng Xue, Dongqing Zhu, Xin Wang, Lina Jiao, Yunhui Lu, Sanli Zhang, Jiayi Lv, Linlin Cui, Mengna Ruan, Dechao Xu, Qingyang Liu, Yun Feng, Shuqin Mei
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Pembrolizumab and other immunotherapies have become central in treating metastatic colon cancer, particularly effective in patients with mismatch repair deficiencies. We report a case involving a man who initially underwent radical surgery for sigmoi
Externí odkaz:
https://doaj.org/article/5513756500494c81b1672d80746b0a36
Autor:
Linxi Huang, Cheng Xue, Jianke Kuai, Mengna Ruan, Bo Yang, Xujiao Chen, Yu Zhang, Yixin Qian, Jun Wu, Xuezhi Zhao, Changlin Mei, Jing Xu, Zhiguo Mao
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 5, Pp 879-896 (2019)
Background: The different clinical characteristics of community-acquired acute kidney injury (CA-AKI) versus hospital-acquired AKI (HA-AKI) have remained inconclusive, and thus, a meta-analysis was conducted to summarize and quantify the clinical sig
Externí odkaz:
https://doaj.org/article/262d299cfce64835aa2bdab985addd96
Publikováno v:
International Urology and Nephrology. 54:2375-2383
Crescentic glomerulonephritis (CrGN) represents a severe form of glomerular injury that results in high rates of renal failure. This study aimed to investigate the influence of potential clinical and pathological factors on renal outcomes of CrGN; an
Autor:
Jing Xu, Cheng Xue, Yuqiang Zhang, Shoulian Zhou, Xuezhi Zhao, Sixiu Chen, Mengna Ruan, Yixin Qian, Linxi Huang, Bo Yang, Zhiguo Mao, Changlin Mei, Jun Wu
Publikováno v:
Blood Purification. 51:328-344
Background: The optimal technique for inserting peritoneal dialysis catheters in uremic patients remains debated. This meta-analysis aimed to summarize the current evidence evaluating the efficacy and safety of percutaneous insertion methods compared
Autor:
Yuanfang Ma, Peiyao Li, Shulian Li, Yan Zhang, Jielu Hao, Zijun Du, Mengna Ruan, Jinghua Hu, Qiang Lou
Publikováno v:
Journal of Cellular and Molecular Medicine
Cisplatin nephrotoxicity has been considered as serious side effect caused by cisplatin‐based chemotherapy. Recent evidence indicates that renal tubular cell apoptosis and inflammation contribute to the progression of cisplatin‐induced acute kidn
Publikováno v:
Nephron. 145:353-362
Objectives: The determinants leading to different renal outcomes in community-acquired acute kidney injury (CA-AKI) and the influence of renal histological damage on the prognosis and recovery of CA-AKI are scarcely reported. Methods: Adult patients
Autor:
Shoulian Zhou, Lili Fu, Sixiu Chen, Bo Yang, Linxi Huang, Qingzhou Zhang, Changlin Mei, Dechao Xu, Mengna Ruan, Zhiguo Mao
Publikováno v:
Journal of Cellular and Molecular Medicine
Autosomal‐dominant polycystic kidney disease (ADPKD) is characterized by uncontrolled renal cyst formation, and few treatment options are available. There are many parallels between ADPKD and clear‐cell renal cell carcinoma (ccRCC); however, few
Autor:
Xujiao Chen, Bo Yang, Linxi Huang, Jing Xu, Zhiguo Mao, Jun Wu, Cheng Xue, Yixin Qian, Changlin Mei, Yu Zhang, Xuezhi Zhao, Jianke Kuai, Mengna Ruan
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 5, Pp 879-896 (2019)
Background: The different clinical characteristics of community-acquired acute kidney injury (CA-AKI) versus hospital-acquired AKI (HA-AKI) have remained inconclusive, and thus, a meta-analysis was conducted to summarize and quantify the clinical sig
Autor:
Sixiu Chen, Linxi Huang, Shoulian Zhou, Qingzhou Zhang, Mengna Ruan, Lili Fu, Bo Yang, Dechao Xu, Changlin Mei, Zhiguo Mao
Publikováno v:
Journal of Cellular & Molecular Medicine; Oct2021, Vol. 25 Issue 20, p9597-9608, 12p
Autor:
Cheng Xue, Zhiguo Mao, Changlin Mei, Xujiao Chen, Yuqiang Zhang, Shou-Lin Zhang, Linxi Huang, Sixiu Chen, Cheng-Ji Cui, Chenchen Zhou, Jun Wu, Bo Yang, Xuezhi Zhao, Mengna Ruan, Yan-Yan Gu, Jing Xu, Yixin Qian, Xian-Dong Wang
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 35(8)
Background Peritoneal dialysis (PD) patients are at high risk of developing glucose metabolism disturbance (GMD). The incidence and prevalence of new-onset GMD, including diabetes mellitus (DM), impaired glucose tolerance (IGT) and impaired fast gluc